Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Low Disease Activity Over 4 Years of Ocrelizumab Therapy in Treatment-naive Patients with High-activity, Early-stage Relapsing-remitting Multiple Sclerosis in the ENSEMBLE Study

              Author:Vollmer, Timothy   Bermel, Robert   Brochet, Bruno   Berger, Thomas   Carroll, William   Freedman, Mark   Holmoy, Trygve   Karabudak, Rana   Killestein, Joep   Nos, Carlos   Patti, Francesco   Vanopdenbosch, Ludo   Kuenzel, Thomas   Kadner, Karen   Kulyk, Inessa   Hartung, Hans-Peter   

              Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

              Topic:Multiple Sclerosis  

              Program Number:P10.007  

              Author Institution:University of Colorado, Aurora, CO  Cleveland Clinic, Cleveland, OH  Université de Bordeaux, Neurocentre Magendie INSERM, Bordeaux, France  Dept. of Neurology, Medical University of Vienna, Vienna, Austria  The University of Western Australia, Nedlands, Australia  University of Ottawa, Ottawa, ON, Canada  Akershus University Hospital, Lorenskog, Norway  Hacettepe University Faculty of Medicine, Ankara, Turkey  VU University Medical Centre, Amsterdam, Netherlands  Vall d’Hebron Hospital Universitari, Barcelona, Spain  University of Catania PO Policlinico G Rodolico, Catania, Italy  AZ Sint-Jan Brugge, Brugge, Belgium  F. Hoffmann-La Roche Ltd., Basel, Switzerland  Department of Neurology, Heinrich-Heine University, Dusseldorf, Germany